Welcome to Valicare!
GMP consulting and compliance is one of our strengths. Whether GAP analyses, conceptual design, updating or implementation of a GMP system, our GMP experts support you competently and efficiently.Learn more
2nd APV Interactive Workshop on ATMP. "Bridging standard pharma concepts and ATMP", 05.10. - 06.10.2021, Frankfurt on the Main, Germany: inform and register now!Learn more
20 Sep 202121 Sep 2021Stuttgart/Germany German Biotechnology Days, 20.09. - 21.09.2021, Stuttgart/Germany Germany's largest biotech event, the German Biotechnology Days 2021, the forum for the exchange of experience between all players in the German biotechnology scene, will take place in Stuttgart from 20-21 September.
05 Oct 202106 Oct 2021Frankfurt am Main/Germany 2nd APV Interactive Workshop on ATMP, 05.10. – 06.10.2021, Frankfurt am Main / Deutschland The workshop focuses on Advanced Therapy Medical Products (ATMP) as products in development for market supply.
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
Tumor-on-chip modeling of organ-specific cancer and metastasis24.07.2021 | Science Direct
Abstract Every year, cancer claims millions of lives around the globe. Unfortunately, model systems that accurately mimic human oncology – ...
Chemotherapy can induce mutations that lead to pediatric leukemia relapse23.07.2021 | Medical Xpress
Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in ...
Erste ambulante CAR-T-Zell-Therapie22.07.2021 | Management & Krankenhaus
European Commission Approves Bluebird Bio’s Gene Therapy for CALD - Global Genes21.07.2021 | Global Genes
Rare Daily Staff The European Commission has granted marketing authorization to Bluebird Bio’s Skysona, a one-time gene therapy for the ...
Money on the Move: July 14 – 2121.07.2021 | Bio Space
Published: Jul 21, 2021 By Kate Goodwin More money means more progress for potentially life-saving therapies. Here's a peek at some ...
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters21.07.2021 | Frontiers
The immunotherapeutic treatment of various cancers with an increasing number of immune checkpoint inhibitors (ICIs) has profoundly improved ...
FDA Approves StrataGraft for Treating Thermal Burns in Adults21.07.2021 | U.S. Pharmacist
In a press release on June 15, 2021, the FDA announced the approval of StrataGraft (allogeneic cultured keratinocytes and dermal ...
Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome21.07.2021 | The Canadian Business Journal
Pipeline Update: Status of Clinical Development for Multiple Sclerosis20.07.2021 | neurologylive
The state of care for multiple sclerosis (MS) has evolved drastically in the last decade, with much of the development of disease-modifying ...
Clinical Catch-Up: July 12-1619.07.2021 | Bio Space
Published: Jul 19, 2021 By Mark Terry It was a moderately busy mid-summer week for clinical trial news. Here’s a look. COVID-19-Related ...
BioNTech übernimmt Kites Neoantigen-TCR-Zelltherapie-Plattform sowie Produktionsstätte im amerikanischen Gaithersburg19.07.2021 | BAWAG P.S.K. Chartmix
MAINZ, Deutschland & Santa Monica, USA 19. Juni 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) und Kite, ein Unternehmen der Gilead-Gruppe ...
B7-H3/CD276: An Emerging Cancer Immunotherapy19.07.2021 | Frontiers
Immunotherapy aiming at suppressing tumor development by relying on modifying or strengthening the immune system prevails among cancer ...
Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility16.07.2021 | BioPharm International
The GMP facility is designed to maximize bioprocessing efficiency of newborn stem cells and manufacturing at scale.
EMA OKs Biomarin’s New Application to Approve Roctavian16.07.2021 | Hemophilia News Today
The European Medicines Agency (EMA) has validated BioMarin Pharmaceutical’s new application seeking approval of its investigational one- ...
Celltrion's Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates Strong Neutralising Activity Against Delta Variant16.07.2021 | The Financial Post